1. Barinova A.N., Plavinskii S.L., Vinogradova N.Kh. Ispol'zovanie odnomomentnykh dannykh dlya otsenki intensivnosti zarazheniya potrebitelei in\"ektsionnykh narkotikov VICh-infektsiei i virusnym gepatitom S - otsutstvie postoyanstva riska. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im I.I. Mechnikova. 2015;7(1):78-87.
2. Eritsyan K.Yu., Kornilova M.S., Odinokova V.A. Otchet po rezul'tatam dozornogo biopovedencheskogo issledovaniya po VICh-infektsii sredi potrebitelei in\"ektsionnykh narkotikov v gg. Abakan, Barnaul, Volgograd, Perm', Naberezhnye Chelny. Moskva: NP Esvero; 2015.
3. Plavinskii S.L., Bobrik A.V., Barinova A.N., Eroshina K.M., Novozhilov A.V. Effektivnost' programm snizheniya vreda dlya predotvrashcheniya rasprostraneniya VICh-infektsii v Rossiiskoi Federatsii. Rossiiskii semeinyi vrach. 2009, 13(2):20-24.
4. Pokrovskii V.V., Ladnaya N.N., Sokolova E.V. VICh-infektsiya. Informatsionnyi byulleten' № 42 Federal'nyi nauchno-metodicheskii tsentr po profilaktike i bor'be so SPIDom FBUN TsNIIE Rospotrebnadzora, 2018.
5. Cepeda J.A., Eritsyan K., Vickerman P. et al. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV. 2018 S2352-3018(18): 30168-78.